The NYT reports:
The chief executive of the aerospace giant Boeing downplayed the fallout from the president’s decision to withdraw from the Iran nuclear pact, saying on Wednesday that the company would abide by the Trump administration’s decision to cancel Boeing’s licenses to sell $20 billion of aircraft to Iran.
“We will continue to follow the U.S. government’s lead,” Dennis A. Muilenburg, the chief executive, told a luncheon crowd at the Economic Club of Washington.
(click here to continue reading Boeing C.E.O. Downplays Loss of $20 Billion Contract With Iran – The New York Times.)
Craven. Is there any other word for it? $20,000,000,000 is a rather large contract, wouldn’t you say?
I wouldn’t be surprised if Boeing has had discussions with Michael Cohen for a “consultant” deal, like AT&T, Novartis, or Korea Aerospace Industries. I wonder if Boeing agreed to it? I’m guessing they did not, and thus Trump has gone out of his way to antagonize Boeing.
3rd World Man:
Among the other payments to Mr. Cohen’s company described in the financial records were four for $99,980 each between October and January by Novartis Investments S.A.R.L., a subsidiary of Novartis, the multinational pharmaceutical giant based in Switzerland. Novartis — whose chief executive was among 15 business leaders invited to dinner with Mr. Trump at the World Economic Forum in January — spent more than $10 million on lobbying in Washington last year and frequently seeks approvals from federal drug regulators. Novartis said in a statement that its agreement with Essential Consultants had expired.
In addition, Korea Aerospace Industries paid Mr. Cohen’s company $150,000 last November, according to the records. The company, an aircraft manufacturer, has teamed with the American defense contractor Lockheed Martin in competing for a multibillion-dollar contract to provide trainer jets for the United States Air Force that is expected to be awarded this year.
(click here to continue reading Firm Tied to Russian Oligarch Made Payments to Michael Cohen – The New York Times.)